Treatment of lung cancer with active vitamin D compounds in combination with other treatments

Details for Australian Patent Application No. 2004265238 (hide)

Owner Novacea, Inc.

Inventors Henner, William D.

Agent Houlihan2

Pub. Number AU-A-2004265238

PCT Pub. Number WO2005/016872

Priority 60/569,245 10.05.04 US; 60/477,339 11.06.03 US

Filing date 10 June 2004

Wipo publication date 24 February 2005

International Classifications

C07C 401/00 (2006.01) Irradiation products of cholesterol or its derivatives

A61K 31/59 (2006.01) - Compounds containing 9,10-seco-cyclopenta[a]hydro- phenanthrene ring systems

Event Publications

22 December 2005 PCT application entered the National Phase

  PCT publication WO2005/016872 Priority application(s): WO2005/016872

14 January 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004265243-N-phenyl-piperazine derivatives and methods of prophylaxis or treatment of 5HT2c receptor associated diseases

2004265235-Use of disulfonated anthracenes as inert fluorescent tracers